'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Ovarian Cancer|Breast Cancer|Prostate Cancer|Pancreatic Cancer
Sponsor: AstraZeneca